Inhibition of endoplasmic reticulum stress alleviates triple-negative breast cancer cell viability, migration, and invasion by Syntenin/SOX4/Wnt/β-catenin pathway via regulation of heat shock protein A4

References

• Foulkes WD, Smith IE, Reis-Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–1948.
   PubMed Web of Science ®Google Scholar
• Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res off J Am Assoc Cancer Res. 2007;13:4429–4434.
   PubMed Web of Science ®Google Scholar
• Li C, Fan Z, Lin X, et al. Parity and risk of developing breast cancer according to tumor subtype: a systematic review and meta-analysis. Cancer Epidemiol. 2021;75:102050.
   PubMed Web of Science ®Google Scholar
• Zeng X, Ma X, Guo H, et al. MicroRNA-582-5p promotes triple-negative breast cancer invasion and metastasis by antagonizing CMTM8. Bioengineered. 2021;12:10126–10135.
   PubMed Web of Science ®Google Scholar
• Miller K, Wang M, Gralow J, et al. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer. N Engl J Med. 2007;357:2666–2676.
   PubMed Web of Science ®Google Scholar
• Yin L, Duan JJ, Bian XW, et al. Triple-negative breast cancer molecular subtyping and treatment progress. BCR. 2020;22:61.
   PubMed Web of Science ®Google Scholar
• Bianchini G, Balko JM, Mayer IA, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol. 2016;13:674–690.
   PubMed Web of Science ®Google Scholar
• Wang WA, Groenendyk J, Michalak M. Endoplasmic reticulum stress associated responses in cancer. Biochim Biophys Acta. 2014;1843:2143–2149.
   PubMed Web of Science ®Google Scholar
• Xu C, Bailly-Maitre B, Reed JC. Endoplasmic reticulum stress: cell life and death decisions. J Clin Invest. 2005;115:2656–2664.
   PubMed Web of Science ®Google Scholar
• Corazzari M, Gagliardi M, Fimia GM, et al. Endoplasmic reticulum stress, unfolded protein response, and cancer cell fate. Front Oncol. 2017;7:78.
   PubMed Web of Science ®Google Scholar
• Sisinni L, Pietrafesa M, Lepore S, et al. Endoplasmic reticulum stress and unfolded protein response in breast cancer: the balance between apoptosis and autophagy and its role in drug resistance. Int J Mol Sci. 2019;20:857.
   PubMed Web of Science ®Google Scholar
• Paridaens A, Laukens D, Vandewynckel YP, et al. Endoplasmic reticulum stress and angiogenesis: is there an interaction between them? Liver Int. 2014;34:e10–18.
   PubMed Web of Science ®Google Scholar
• Giampietri C, Petrungaro S, Conti S, et al. Cancer microenvironment and endoplasmic reticulum stress response. Mediators Inflamm. 2015;2015:417281.
   PubMed Web of Science ®Google Scholar
• Cubillos-Ruiz JR, Bettigole SE, Glimcher LH. Tumorigenic and immunosuppressive effects of endoplasmic reticulum stress in cancer. Cell. 2017;168:692–706.
   PubMed Web of Science ®Google Scholar
• King AP, Wilson JJ. Endoplasmic reticulum stress: an arising target for metal-based anticancer agents. Chem Soc Rev. 2020;49:8113–8136.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhou X, Sun J, et al. Reactive oxygen species mediate anlotinib-induced apoptosis via activation of endoplasmic reticulum stress in pancreatic cancer. Cell Death Dis. 2020;11:766.
   PubMed Web of Science ®Google Scholar
• Du Y, Wang M, Liu X, et al. Araloside C prevents hypoxia/reoxygenation-induced endoplasmic reticulum stress via increasing heat shock protein 90 in H9c2 cardiomyocytes. Front Pharmacol. 2018;9:180.
   PubMed Web of Science ®Google Scholar
• Nowakowska M, Gualtieri F, von Rüden EL, et al. Profiling the expression of endoplasmic reticulum stress associated heat shock proteins in animal epilepsy models. Neuroscience. 2020;429:156–172.
   PubMed Web of Science ®Google Scholar
• Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods. 2005;35:373–381.
   PubMed Web of Science ®Google Scholar
• Baumeister P, Luo S, Skarnes WC, et al. Endoplasmic reticulum stress induction of the Grp78/BiP promoter: activating mechanisms mediated by YY1 and its interactive chromatin modifiers. Mol Cell Biol. 2005;25:4529–4540.
   PubMed Web of Science ®Google Scholar
• Zheng YZ, Cao ZG, Hu X, et al. The endoplasmic reticulum stress markers GRP78 and CHOP predict disease-free survival and responsiveness to chemotherapy in breast cancer. Breast Cancer Res Treat. 2014;145:349–358.
   PubMed Web of Science ®Google Scholar
• Louessard M, Bardou I, Lemarchand E, et al. Activation of cell surface GRP78 decreases endoplasmic reticulum stress and neuronal death. Cell Death Differ. 2017;24:1518–1529.
   PubMed Web of Science ®Google Scholar
• Storniolo A, Raciti M, Cucina A, et al. Quercetin affects Hsp70/IRE1α mediated protection from death induced by endoplasmic reticulum stress. Oxid Med Cell Longev. 2015;2015:645157.
   PubMed Web of Science ®Google Scholar
• Park SH, Bolender N, Eisele F, et al. The cytoplasmic Hsp70 chaperone machinery subjects misfolded and endoplasmic reticulum import-incompetent proteins to degradation via the ubiquitin-proteasome system. Mol Biol Cell. 2007;18:153–165.
   PubMed Web of Science ®Google Scholar
• Liu B, Xu Y, Zhang L, et al. Hypermethylation of DLG3 promoter upregulates RAC1 and activates the PI3K/AKT signaling pathway to promote breast cancer progression. Evid Based Complement Alternat Med. 2021;2021:8428130.
   PubMed Web of Science ®Google Scholar
• Li L, Wei D, Zhang J, et al. miR-641 inhibited cell proliferation and induced apoptosis by targeting NUCKS1/PI3K/AKT signaling pathway in breast cancer. Comput Math Methods Med. 2022;2022:5203839.
   PubMed Web of Science ®Google Scholar
• Li H, Zhang H, Tan X, et al. Overexpression of ING3 is associated with attenuation of migration and invasion in breast cancer. Exp Ther Med. 2021;22:699.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402–408.
   PubMed Web of Science ®Google Scholar
• Han B, Wang T, Xue Z, et al. Elemene nanoemulsion inhibits metastasis of breast cancer by ROS scavenging. Int J Nanomedicine. 2021;16:6035–6048.
   PubMed Web of Science ®Google Scholar
• Zhang M, Meng M, Liu Y, et al. Triptonide effectively inhibits triple-negative breast cancer metastasis through concurrent degradation of Twist1 and Notch1 oncoproteins. BCR. 2021;23:116.
   PubMed Web of Science ®Google Scholar
• O’Reilly EA, Gubbins L, Sharma S, et al. The fate of chemoresistance in triple negative breast cancer (TNBC). BBA Clin. 2015;3:257–275.
   PubMed Web of Science ®Google Scholar
• Hon JD, Singh B, Sahin A, et al. Breast cancer molecular subtypes: from TNBC to QNBC. Am J Cancer Res. 2016;6:1864–1872.
   PubMed Web of Science ®Google Scholar
• Sarkar D, Boukerche H, Su ZZ, et al. mda-9/Syntenin: more than just a simple adapter protein when it comes to cancer metastasis. Cancer Res. 2008;68:3087–3093.
   PubMed Web of Science ®Google Scholar
• Lambaerts K, Wilcox-Adelman SA, Zimmermann P. The signaling mechanisms of syndecan heparan sulfate proteoglycans. Curr Opin Cell Biol. 2009;21:662–669.
   PubMed Web of Science ®Google Scholar
• Grootjans JJ, Reekmans G, Ceulemans H, et al. Syntenin-syndecan binding requires syndecan-synteny and the co-operation of both PDZ domains of syntenin. J Biol Chem. 2000;275:19933–19941.
   PubMed Web of Science ®Google Scholar
• Grootjans JJ, Zimmermann P, Reekmans G, et al. Syntenin, a PDZ protein that binds syndecan cytoplasmic domains. Proc Natl Acad Sci U S A. 1997;94:13683–13688.
   PubMed Web of Science ®Google Scholar
• Koo TH, Lee JJ, Kim EM, et al. Syntenin is overexpressed and promotes cell migration in metastatic human breast and gastric cancer cell lines. Oncogene. 2002;21:4080–4088.
   PubMed Web of Science ®Google Scholar
• Liu J, Qu J, Zhou W, et al. Syntenin-targeted peptide blocker inhibits progression of cancer cells. Eur J Med Chem. 2018;154:354–366.
   PubMed Web of Science ®Google Scholar
• Yang Y, Hong Q, Shi P, et al. Elevated expression of syntenin in breast cancer is correlated with lymph node metastasis and poor patient survival. BCR. 2013;15:R50.
   PubMed Web of Science ®Google Scholar
• Geijsen N, Uings IJ, Pals C, et al. Cytokine-specific transcriptional regulation through an IL-5Ralpha interacting protein. Science. 2001;293:1136–1138.
   PubMed Web of Science ®Google Scholar
• Beekman JM, Vervoort SJ, Dekkers F, et al. Syntenin-mediated regulation of Sox4 proteasomal degradation modulates transcriptional output. Oncogene. 2012;31:2668–2679.
   PubMed Web of Science ®Google Scholar
• Wilson M, Koopman P. Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr Opin Genet Dev. 2002;12:441–446.
   PubMed Web of Science ®Google Scholar
• Chen J, Ju HL, Yuan XY, et al. SOX4 is a potential prognostic factor in human cancers: a systematic review and meta-analysis. Clin Transl Oncol. 2016;18:65–72.
   PubMed Web of Science ®Google Scholar
• Zhang P, Li J, Song Y, et al. MiR-129-5p inhibits proliferation and invasion of chondrosarcoma cells by regulating SOX4/Wnt/β-Catenin signaling pathway. Cell Physiol Biochem. 2017;42:242–253.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zeng S, Jiang X, et al. SOX4 induces tumor invasion by targeting EMT-related pathway in prostate cancer. Tumour Biol. 2017;39:1010428317694539.
   Google Scholar
• Zhang J, Liang Q, Lei Y, et al. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression. Cancer Res. 2012;72:4597–4608.
   PubMed Web of Science ®Google Scholar
• Held T, Barakat AZ, Mohamed BA, et al. Heat-shock protein HSPA4 is required for progression of spermatogenesis. Reproduction. 2011;142:133–144.
   PubMed Web of Science ®Google Scholar
• Goloudina AR, Demidov ON, Garrido C. Inhibition of HSP70: a challenging anti-cancer strategy. Cancer Lett. 2012;325:117–124.
   PubMed Web of Science ®Google Scholar
• Boeddeker SJ, Baston-Buest DM, Altergot-Ahmad O, et al. Syndecan-1 knockdown in endometrial epithelial cells alters their apoptotic protein profile and enhances the inducibility of apoptosis. Mol Hum Reprod. 2014;20:567–578.
   PubMed Web of Science ®Google Scholar
• Li Y, Weng X, Wang P, et al. 4-phenylbutyrate exerts stage-specific effects on cardiac differentiation via HDAC inhibition. PLoS One. 2021;16:e0250267.
   PubMed Web of Science ®Google Scholar
• Eom GH, Kook H. Role of histone deacetylase 2 and its posttranslational modifications in cardiac hypertrophy. BMB Rep. 2015;48:131–138.
   PubMed Web of Science ®Google Scholar